Skip to main content
Menu

Respiratory - Paper Rankings

Papers ranked by AI-analyzed total score

RankPaper TitleTotal
1Multiple independent acquisitions of ACE2 usage in MERS-related coronaviruses.
Cell • 2025-02-09
94.5
2Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses.
Cell • 2025-02-09
91.5
3Origin and stepwise evolution of vertebrate lungs.
Nature ecology & evolution • 2025-02-15
90.0
4TGFβ links EBV to multisystem inflammatory syndrome in children.
Nature • 2025-03-13
90.0
5Longitudinal multi-omic signatures of ARDS and sepsis inflammatory phenotypes identify pathways associated with mortality.
The Journal of clinical investigation • 2025-12-02
90.0
6Bat-infecting merbecovirus HKU5-CoV lineage 2 can use human ACE2 as a cell entry receptor.
Cell • 2025-02-20
90.0
7Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis.
The Lancet. Microbe • 2025-12-05
90.0
8Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelae.
Science (New York, N.Y.) • 2025-03-06
90.0
9Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2.
Nature immunology • 2025-01-21
90.0
10In-cell architecture of the mitochondrial respiratory chain.
Science (New York, N.Y.) • 2025-03-20
90.0
11Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2.
Cell • 2025-02-13
90.0
12Human ACE2 transgenic pigs are susceptible to SARS-CoV-2 and develop COVID-19-like disease.
Nature communications • 2025-01-18
90.0
13MFSD6 is an entry receptor for enterovirus D68.
Nature • 2025-03-26
90.0
14Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer.
Nature communications • 2025-02-11
88.5
15Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19.
Nature communications • 2025-03-11
88.5
16Dispersal of influenza virus populations within the respiratory tract shapes their evolutionary potential.
Proceedings of the National Academy of Sciences of the United States of America • 2025-01-21
88.5
17Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis.
The Journal of clinical investigation • 2025-03-03
88.5
18ICOS+CD4+ T cells define a high susceptibility to anti-PD-1 therapy-induced lung pathogenesis.
JCI insight • 2025-04-08
88.5
19Structural Insights into Bortezomib-Induced Activation of the Caseinolytic Chaperone-Protease System in Mycobacterium tuberculosis.
Nature communications • 2025-04-12
88.5
20The Glycosyltransferase XYLT1 Activates NF-κB Signaling to Promote Metastasis of Early-Stage Lung Adenocarcinoma.
Cancer research • 2025-02-24
88.5
21MFSD6 is an entry receptor for respiratory enterovirus D68.
Cell host & microbe • 2025-01-12
88.5
22Lung-resident memory B cells maintain allergic IgE responses in the respiratory tract.
Immunity • 2025-03-27
88.5
23The CXCL8/MAPK/hnRNP-K axis enables susceptibility to infection by EV-D68, rhinovirus, and influenza virus in vitro.
Nature communications • 2025-02-18
88.5
24Histone methyltransferase KMT2A promotes pulmonary fibrogenesis via targeting pro-fibrotic factor PU.1 in fibroblasts.
Clinical and translational medicine • 2025-01-31
87.0
25Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape.
Science advances • 2025-03-28
87.0
26Transcriptional repressor Capicua is a gatekeeper of cell-intrinsic interferon responses.
Cell host & microbe • 2025-03-26
87.0
27Perinatal dysfunction of innate immunity in cystic fibrosis.
Science translational medicine • 2025-01-22
87.0
28Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
The New England journal of medicine • 2025-04-01
87.0
29MUC5AC filaments illuminate the structural diversification of respiratory and intestinal mucins.
Proceedings of the National Academy of Sciences of the United States of America • 2025-03-04
87.0
30Structural and catalytic diversity of coronavirus proofreading exoribonuclease.
Nature communications • 2025-12-09
87.0
31Efficacy, safety, and immunogenicity of the AS01
The Lancet. Respiratory medicine • 2025-04-18
87.0
32Undocking of an extensive ciliary network induces proteostasis and cell fate switching resulting in severe primary ciliary dyskinesia.
Science translational medicine • 2025-01-29
87.0
33Targeting melanocortin 4 receptor to treat sleep-disordered breathing in mice.
The Journal of clinical investigation • 2025-04-15
87.0
34Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials.
The Lancet. Respiratory medicine • 2025-02-02
87.0
35Pandemic monitoring with global aircraft-based wastewater surveillance networks.
Nature medicine • 2025-02-13
86.0
36Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials.
Nature medicine • 2025-04-11
86.0
37Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma.
Nature medicine • 2025-01-14
86.0
38Pre-exposure antibody prophylaxis protects macaques from severe influenza.
Science (New York, N.Y.) • 2025-01-30
86.0
39A lung CT vision foundation model facilitating disease diagnosis and medical imaging.
Nature communications • 2025-12-04
86.0
40Rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in adults: a prospective multicentre study.
The European respiratory journal • 2025-01-03
86.0
41Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2.
Nature biomedical engineering • 2025-03-06
86.0
42Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood.
Nature communications • 2025-12-09
86.0
43Implementation of a stepped anti-inflammatory reliever therapy intervention with budesonide-formoterol 160/4·5 mcg by Turbuhaler versus usual care for adults presenting during exacerbations of obstructive lung disease suggestive of asthma or chronic obstructive pulmonary disease in a resource-limited setting: an open-label, cluster randomised trial.
EClinicalMedicine • 2025-12-04
85.5
44The transcriptome of CD14
The European respiratory journal • 2025-12-09
85.5
45Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial.
JAMA • 2025-12-08
85.5
46Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial.
Nature medicine • 2025-01-08
85.5
47Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.
Nature immunology • 2025-01-29
85.5
48The oxygen level in air directs airway epithelial cell differentiation by controlling mitochondrial citrate export.
Science advances • 2025-01-24
85.5
49Electronic cigarettes for smoking cessation.
The Cochrane database of systematic reviews • 2025-01-29
85.0
50Droplet-based single-cell pairing for high-throughput interaction mapping of antigen-receptor combinations.
Science advances • 2025-12-12
84.5

About Scores

Innovation (0-10)

Degree of novel approaches or discoveries

Impact (0-10)

Potential impact on clinical practice

Rigor (0-10)

Robustness of research methodology

Citation (0-10)

Likelihood of being cited in future research